Skip to content

Clinical trials

Phase 2 Epilepsy trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 2 Country / region: Spain Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20061
20101
20111
20151
20165
20184
20193
20211
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jazz Pharmaceuticals6
Eisai Inc.3
Neurocrine Biosciences3
Takeda2
UCB Biopharma S.P.R.L.2
UCB Pharma2
Bial - Portela C S.A.1
Biohaven Therapeutics Ltd.1
GlaxoSmithKline1
Xenon Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy22
Seizures10
Epilepsies, Partial3
Drug Resistant Epilepsy2
Epilepsies, Myoclonic2
Lennox Gastaut Syndrome2
Brain Diseases1
Central Nervous System Diseases1
Hypoxia-Ischemia, Brain1
Malformations of Cortical Development1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.